Novo Nordisk’s top executive is testifying before senators today over the high prices of the company’s weight loss drug Wegovy and diabetes treatment Ozempic, as demand for both soars.
Rural hospitals and hospitals that treat patients regardless of their ability to pay have been hampered by federal rules limiting their access to funding for capital projects, which has led to institutionalized racism in hospitals, researchers have found.
Weill Cornell Medicine researchers have found that removing protected class regulation from Medicare prescription drug policies could greatly reduce the United States' prescription drug spending, potentially saving $47 billion between 2011 and 2019.
The hormone estrogen regulates binge drinking in females, causing them to “pregame” – consume large quantities of alcohol in the first 30 minutes after it’s offered, according to a preclinical study led by scientists at Weill Cornell Medicine.
A new app developed by Cornell computer science researchers helps users record highly accurate time-lapse videos of body parts – a surprisingly difficult task and an unmet need in remote medicine and telehealth applications.
Cornell's newest interdisciplinary EEG lab could help faculty make breakthroughs in fields ranging from psychology to neurology to artificial intelligence.
An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies, according to a preclinical study led by Weill Cornell Medicine lymphoma researchers.
Dr. Chani Traube, professor of pediatrics at Weill Cornell Medicine, has been awarded a $3.4 million grant from the National Institutes of Health for a clinical trial called Optimizing Pain Treatment in Children on Mechanical ventilation.
